🇺🇸 LIFILEUCEL in United States

102 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 16 reports (15.69%)
  2. Acute Kidney Injury — 14 reports (13.73%)
  3. Hypotension — 14 reports (13.73%)
  4. Chills — 10 reports (9.8%)
  5. Cytokine Release Syndrome — 9 reports (8.82%)
  6. Respiratory Failure — 9 reports (8.82%)
  7. Thrombocytopenia — 9 reports (8.82%)
  8. Diarrhoea — 7 reports (6.86%)
  9. Hypoxia — 7 reports (6.86%)
  10. Multiple Organ Dysfunction Syndrome — 7 reports (6.86%)

Source database →

LIFILEUCEL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LIFILEUCEL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for LIFILEUCEL in United States?

Marketing authorisation holder not available in our data.